Avalo Therapeutics Inc (AVTX)
14.00
-0.36
(-2.51%)
USD |
NASDAQ |
May 06, 10:19
Avalo Therapeutics Total Return Level: 14.36 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 14.36 |
May 02, 2024 | 15.39 |
May 01, 2024 | 16.00 |
April 30, 2024 | 17.12 |
April 29, 2024 | 16.88 |
April 26, 2024 | 15.94 |
April 25, 2024 | 14.98 |
April 24, 2024 | 14.20 |
April 23, 2024 | 13.00 |
April 22, 2024 | 12.21 |
April 19, 2024 | 11.63 |
April 18, 2024 | 12.01 |
April 17, 2024 | 13.62 |
April 16, 2024 | 15.94 |
April 15, 2024 | 15.24 |
April 12, 2024 | 14.90 |
April 11, 2024 | 15.75 |
April 10, 2024 | 15.06 |
April 09, 2024 | 14.48 |
April 08, 2024 | 14.19 |
April 05, 2024 | 16.40 |
April 04, 2024 | 16.30 |
April 03, 2024 | 16.31 |
April 02, 2024 | 15.16 |
April 01, 2024 | 17.90 |
Date | Value |
---|---|
March 28, 2024 | 21.75 |
March 27, 2024 | 4.75 |
March 26, 2024 | 4.624 |
March 25, 2024 | 4.84 |
March 22, 2024 | 4.88 |
March 21, 2024 | 4.60 |
March 20, 2024 | 4.47 |
March 19, 2024 | 4.35 |
March 18, 2024 | 4.44 |
March 15, 2024 | 4.37 |
March 14, 2024 | 5.00 |
March 13, 2024 | 5.52 |
March 12, 2024 | 5.45 |
March 11, 2024 | 5.62 |
March 08, 2024 | 5.88 |
March 07, 2024 | 5.24 |
March 06, 2024 | 5.17 |
March 05, 2024 | 4.50 |
March 04, 2024 | 4.60 |
March 01, 2024 | 4.42 |
February 29, 2024 | 4.41 |
February 28, 2024 | 4.44 |
February 27, 2024 | 4.67 |
February 26, 2024 | 4.35 |
February 23, 2024 | 4.28 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
4.02
Minimum
Jan 17 2024
16444.80
Maximum
Jun 13 2019
5156.97
Average
6192.00
Median
Apr 07 2020
Total Return Level Benchmarks
Imunon Inc | 1.33 |
iBio Inc | 1.99 |
Kodiak Sciences Inc | 3.77 |
Petros Pharmaceuticals Inc | 0.7133 |
Ocugen Inc | 1.33 |